Novo Nordisk slashes prices of additional insulin products but not until 2026

After slashing the U.S. prices of several of its insulin products by 75% at the start of 2024, Novo Nordisk is ending the year by announcing similar price reductions for most of its other insulins for patients who have diabetes.